All In Biotech

Drug Trial Radar · NCT05213676

De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia

Inhaled Nitric Oxide (iNO) for Congenital Diaphragmatic Hernia (CDH) - The "NoNO Trial" - a Multi-center, De-implementation, Stepped-wedge, Cluster-randomized Trial Within an Established Collaborative

Last checked: Nov 20, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 900 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

900

Planned (sponsor's estimate)

Start

Nov 1, 2025

Primary completion

Oct 31, 2030

Study completion Apr 30, 2031

Sponsor

Lead sponsor
The University of Texas Health Science Center, HoustonAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University of Tennessee & LeBonheur Children's Hospital (UT-LBCH); Children's Hospital of Orange County; Medical University of South Carolina Children's Health (MUSC); University of Michigan & CS Mott Children's Hospital (UM-CSMott); Randall Children's Hospital-Portland (RCH); Stanford University & Lucile Packard Children's Hospital (Stanford-LPCH); Rady Children's Hospital, San Diego; Boston Children's Hospital; Indiana University & Riley Children's Hospital (IU-RiCH); Norton Children's Hospital; University of Utah & Primary Children's Hospital (Utah-PCH); University of Washington & Seattle Children's Hospital (UW-SCH); University of Alabama & Children's Hospital of Alabama (UAB-CoA); University of Arkansas; Vanderbilt University Medical Center; University of Southern California & Children's Hospital Los Angeles (USC-CHLA); Emory University & Children's Healthcare of Atlanta (CHOA); Children's Hospital Colorado
First posted
Jan 28, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 0 months, up to 1 month
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine if de-implementation of inhaled nitric oxide (iNO) in the post-natal resuscitation/stabilization phase affects the composite outcome of extracorporeal life support (ECLS) use and/or mortality, as well as ECLS use, mortality, and/or oxygenation in congenital diaphragmatic hernia (CDH) newborns and to establish the cost-effectiveness of de-implementing iNO as a therapy in the postnatal resuscitation/stabilization phase of CDH management, which will be assessed as the incremental health system costs (savings) per prevented ECLS use and/or death.

Conditions

  • Congenital Diaphragmatic Hernia

Interventions

  • Inhaled Nitric Oxide (iNO) useDrug

    The center will use iNO per their usual protocol in the initial resuscitation period (defined as birth through stabilization and CDH repair). No center will alter any component of their standard clinical practice guideline or protocol governing CDH care.

  • De-implementation of Inhaled Nitric Oxide (iNO) useOther

    The center will stop using iNO in the initial resuscitation period (defined as birth through stabilization and CDH repair).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants who require Extracorporeal Life Support (ECLS) and/or who die prior to dischargeTime frame: from birth through hospital discharge (up to 12 months from birth)

Locations

19 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama & Children's Hospital of Alabama (UAB-CoA)

    Birmingham, Alabama · Recruiting

  • University of Arkansas & Arkansas Children's Hospital (UA-ACH)

    Little Rock, Arkansas · Recruiting

  • University of California-Irvine & Children's Hospital of Orange County (UC-CHOC)

    Irvine, California · Recruiting

  • University of Southern California & Children's Hospital Los Angeles (USC-CHLA)

    Los Angeles, California · Recruiting

  • Stanford University & Lucile Packard Children's Hospital (Stanford-LPCH)

    Palo Alto, California · Recruiting

  • University of California, San Diego & Rady Children's Hospital (UCSD-Rady)

    San Diego, California · Recruiting

  • University of Colorado & Children's Hospital of Colorado (CU-CHC)

    Aurora, Colorado · Recruiting

  • Emory University & Children's Healthcare of Atlanta (CHOA)

    Atlanta, Georgia · Recruiting

  • Indiana University & Riley Children's Hospital (IU-RiCH)

    Indianapolis, Indiana · Recruiting

  • University of Louisville & Norton Children's Hospital (UL-NCH)

    Louisville, Kentucky · Recruiting

  • Harvard University & Boston Children's Hospital (Harvard-BCH)

    Boston, Massachusetts · Recruiting

  • University of Michigan & CS Mott Children's Hospital (UM-CSMott)

    Ann Arbor, Michigan · Recruiting

  • Randall Children's Hospital-Portland (RCH)

    Portland, Oregon · Recruiting

  • Medical University of South Carolina Children's Health (MUSC)

    Charleston, South Carolina · Recruiting

  • University of Tennessee & LeBonheur Children's Hospital (UT-LBCH)

    Memphis, Tennessee · Recruiting

  • Vanderbilt University & Vanderbilt University Medical Center (VUMC)

    Nashville, Tennessee · Recruiting

  • The University of Texas Health Science Center at Houston

    Houston, Texas · Recruiting

  • University of Utah & Primary Children's Hospital (Utah-PCH)

    Salt Lake City, Utah · Recruiting

  • University of Washington & Seattle Children's Hospital (UW-SCH)

    Seattle, Washington · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.